In January, Palmetto GBA, a Medicare administrative contractor that administers the Molecular Diagnostics Services program (MolDX), granted coverage for the Guardant Reveal test to monitor for ...

Guardant Health (NASDAQ:GH) traded higher in the morning hours on Tuesday after the company announced that the U.S. Centers for Medicare & Medicaid Services (CMS) issued Advanced Diagnostic ...

(RTTNews) - Guardant Health, Inc. (GH) Tuesday announced that the Centers for Medicare & Medicaid Services or CMS has granted Advanced Diagnostic Laboratory Test or ADLT status to its Shield blood ...

Guardant Health (NASDAQ:GH), a leader in precision oncology testing, announced its fourth-quarter results on Feb. 20. Total revenue rose 30% year over year to $201.8 million, outpacing analysts ...

"This partnership will enable our healthcare providers to utilize Guardant’s precision oncology testing to help detect cancer earlier, develop a targeted treatment program for each individual ...